
Founded in 2018 by Alice Newcombe-Ellis alongside co-founding Science Partners, Ahren is a deep tech and deep science investment firm based in London, Cambridge, and Boston. The firm operates a distinctive model pairing commercially active long term capital with world leading scientists, including Nobel laureates Venki Ramakrishnan and Gregory Winter, and Turing Award winner Shankar Balasubramanian. Ahren invests from pre-seed to pre-IPO, partnering with founders building transformational companies that penetrate or create massive markets. Notable portfolio companies include Graphcore, AI21 Labs, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics.